The global biochips market exhibited strong growth during 2015-2020.
Looking forward, the analyst expects the market to grow at a CAGR of around 15% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Biochips refer to a miniaturized medical device that includes a wide collection of microarrays for performing multiple biochemical reactions simultaneously. They contain numerous biosensors that enable the screening of several biological analytes such as enzymes, proteins, DNA, biological molecules, antibodies, etc. Biochips are primarily used in drug discovery, in-vitro diagnostics, gene expression profiling, single nucleotide polymorphism genotyping, agricultural biotechnology, etc. As a result, they are widely adopted across various pharmaceutical and biotechnology companies, research and academic laboratories, and healthcare facilities. The increasing prevalence of chronic disorders along with the rising geriatric population is currently driving the demand for biochips in the medical sector. In recent times, the growing incidences of cancer have also augmented the use of biochips for the early detection of cancerous cells in the body. In line with this, biochips are increasingly being adopted for developing targeted and personalized medicines for cancer treatment. Additionally, the growing consumer health concerns towards several viral infections and immunological disorders are also propelling the demand for biochips in new drug discovery and development activities. For instance, with the outbreak of the COVID-19 pandemic, several biotechnology and pharma companies are focusing on developing novel biochips for detecting the infection in the body. Moreover, rising advancements in microfluid technology have led to the introduction of specifically engineered biochips for various laboratory procedures. Furthermore, numerous R&D activities in the biotechnology sector have also led to the emergence of digital microfluidic biochips. The changing consumer inclination towards minimally invasive surgeries coupled with rising upgradations in nanotechnology are further driving the demand for biochips. Apart from this, the growing investments in the healthcare sector pertaining to cancer genomics, human proteome, and DNA-analysis are further anticipated to catalyze the global biochips market.
Key Market Segmentation: the analyst provides an analysis of the key trends in each sub-segment of the global biochips market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product type, fabrication technique, analysis method, application and end user.
Breakup by Product Type: DNA Chip Protein Chip Lab-On-a-Chip Enzyme Chip
Breakup by Fabrication Technique: Microarray Microfluidic
Breakup by Analysis Method: Electrophoresis Luminescence Mass Spectrometry Electrical Signals Magnetism
Breakup by Application: Molecular Analysis Hybridization Protein Immunological Biomolecules Biomarker Others Diagnosis Gene Diagnosis Oncology Inflammatory Others Non-Biological Usage
Breakup by End User: Pharmaceutical and Biotechnology Companies Hospitals and Diagnostics Centers Academic & Research Institutes Others
Breakup by Region: North America United States Canada Europe Germany France United Kingdom Spain Russia Italy Others Asia Pacific China Japan India South Korea Australia Others Latin America Mexico Brazil Argentina Others Middle East and Africa Turkey Saudi Arabia United Arab Emirates Others
Competitive Landscape: The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, Inc., bioMérieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global biochips market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global biochips market? What are the key regional markets? What is the breakup of the market based on the product type? What is the breakup of the market based on the fabrication technique? What is the breakup of the market based on the analysis method? What is the breakup of the market based on the application? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the market? What is the structure of the global biochips market and who are the key players? What is the degree of competition in the market?
Our reports have been used by over 10K customers, including:
The global venture capital investment market reached a value of US$ 197.7 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of around 16% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...
Marine Biotechnology Market Review 2021 and Strategic Plan for 2022 - Insights, Trends, Competition, Growth Opportunities, Market Size, Market Share Data and Analysis Outlook to 2028 Marine Biotechnology Market Market Overview Marine Biotechnology Market market is expected to register an attractive...
The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of distribution agreements from...
The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010 - 2021 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering...
The aptamers market valued at an estimated USD 151 million in 2021 and is projected to reach USD 342 million by 2026, at a CAGR of 17.7% during the forecast period. Growth of aptamers market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the biosimilar therapeutic peptides market are Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline (GSK), Novartis AG, and Novo Nordisk A/S. The global biosimilar therapeutic peptides market is expected to grow from $0.76 billion in 2020 to $0.87...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the research antibodies and reagents market are Becton Dickinson and Company, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., F. Hoffmann La-Roche Ltd, Merck KGaA, PerkinElmer Inc., Lonza Group AG, Abcam plc, GenScript Biotech Corporation, and Bio-Techne Corporation. The global research antibodies and reagents...
The global track and trace solutions market grew at a CAGR of around 15% during 2015-2020. Track and trace (T&T) solutions help organizations in managing their supply chain and mitigating risks associated with counterfeit products. They offer transparency, product ID verification services, facilitate the hassle-free...
The global prepacked chromatography columns market reached a value of US$ 2.24 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 3.5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.